CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC
Chemokines are important mediators of the immune response to pathogens, but can also promote chronic inflammatory states. Chemokine receptor 6 (CCR6) is found on immature DC and effector/memory T cells, and binds a single ligand, CCL20, with high affinity. Here, we investigated the role of CCL20 and CCR6 in a pulmonary viral infection caused by RSV, a ubiquitous virus that can cause severe pulmonary complications. Neutralization of CCL20 during RSV infection significantly reduced lung pathology and favored a Th1 effector response. CCR6-deficient animals recapitulated this phenotype, and additionally showed enhanced viral clearance when compared with WT mice. No differences were observed in migration of T cells to the lungs of CCR6(-/-) animals; however, a significant reduction was observed in numbers of conventional DC (cDC), but not plasmacytoid DC, in CCR6(-/-) mice. A pathogenic phenotype could be reconstituted in CCR6(-/-) mice by supplying cDC into the airway, indicating that mere number of cDC dictates the adverse response. Our data suggest that blockade of the CCL20/CCR6 pathway provides an environment whereby the attenuated recruitment of cDC alters the balance of innate immune cells and mediates the efficient antiviral response to RSV.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2010 |
---|---|
Erschienen: |
2010 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
European journal of immunology - 40(2010), 4 vom: 01. Apr., Seite 1042-52 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kallal, Lara E [VerfasserIn] |
---|
Links: |
---|
Themen: |
82115-62-6 |
---|
Anmerkungen: |
Date Completed 17.05.2010 Date Revised 20.10.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1002/eji.200939778 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM194614026 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM194614026 | ||
003 | DE-627 | ||
005 | 20231223201104.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2010 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/eji.200939778 |2 doi | |
028 | 5 | 2 | |a pubmed24n0649.xml |
035 | |a (DE-627)NLM194614026 | ||
035 | |a (NLM)20101616 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kallal, Lara E |e verfasserin |4 aut | |
245 | 1 | 0 | |a CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC |
264 | 1 | |c 2010 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.05.2010 | ||
500 | |a Date Revised 20.10.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Chemokines are important mediators of the immune response to pathogens, but can also promote chronic inflammatory states. Chemokine receptor 6 (CCR6) is found on immature DC and effector/memory T cells, and binds a single ligand, CCL20, with high affinity. Here, we investigated the role of CCL20 and CCR6 in a pulmonary viral infection caused by RSV, a ubiquitous virus that can cause severe pulmonary complications. Neutralization of CCL20 during RSV infection significantly reduced lung pathology and favored a Th1 effector response. CCR6-deficient animals recapitulated this phenotype, and additionally showed enhanced viral clearance when compared with WT mice. No differences were observed in migration of T cells to the lungs of CCR6(-/-) animals; however, a significant reduction was observed in numbers of conventional DC (cDC), but not plasmacytoid DC, in CCR6(-/-) mice. A pathogenic phenotype could be reconstituted in CCR6(-/-) mice by supplying cDC into the airway, indicating that mere number of cDC dictates the adverse response. Our data suggest that blockade of the CCL20/CCR6 pathway provides an environment whereby the attenuated recruitment of cDC alters the balance of innate immune cells and mediates the efficient antiviral response to RSV | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
650 | 7 | |a CCL20 protein, mouse |2 NLM | |
650 | 7 | |a CCR6 protein, mouse |2 NLM | |
650 | 7 | |a Chemokine CCL20 |2 NLM | |
650 | 7 | |a Receptors, CCR6 |2 NLM | |
650 | 7 | |a Interferon-gamma |2 NLM | |
650 | 7 | |a 82115-62-6 |2 NLM | |
700 | 1 | |a Schaller, Matthew A |e verfasserin |4 aut | |
700 | 1 | |a Lindell, Dennis M |e verfasserin |4 aut | |
700 | 1 | |a Lira, Sergio A |e verfasserin |4 aut | |
700 | 1 | |a Lukacs, Nicholas W |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of immunology |d 1971 |g 40(2010), 4 vom: 01. Apr., Seite 1042-52 |w (DE-627)NLM000108723 |x 1521-4141 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2010 |g number:4 |g day:01 |g month:04 |g pages:1042-52 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/eji.200939778 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2010 |e 4 |b 01 |c 04 |h 1042-52 |